Intensity of FDG Uptake Is Not Everything
- 1 July 2008
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Nuclear Medicine
- Vol. 33 (7), 455-458
- https://doi.org/10.1097/rlu.0b013e31817793bb
Abstract
A growing number of studies have demonstrated the usefulness of FDG PET-CT in the preoperative assessment of soft tissue sarcomas. We report a case of a patient with a known low-grade liposarcoma demonstrating only mild hypermetabolism on a FDG PET-CT study. An incidental osseous lesion was found in the distal tibia of the same extremity during the initial workup. This tibial lesion was significantly more intense on the FDG PET-CT study than the primary sarcoma. Further investigation showed this to be an unexpected benign fibrous dysplasia. We present this case as an example of the discrepancy of FDG activity, which may exist between truly malignant and benign lesions that may arise from soft tissue and osseous structures. A benign process should remain in the differential diagnosis for hypermetabolic lesions when evaluating a case of known malignancy, especially when the degree of uptake of that lesion differs significantly from that of the primary lesion.Keywords
This publication has 9 references indexed in Scilit:
- Avid uptake of [18F]-FDG in fibrous dysplasia can mimic skeletal involvement in Hodgkin’s diseaseEuropean Journal of Nuclear Medicine and Molecular Imaging, 2007
- PET-positive fibrous dysplasia - a potentially misleading incidental finding in a patient with intimal sarcoma of the pulmonary arterySkeletal Radiology, 2007
- Misdiagnosis of Multiple Bone Metastases Due to Increased FDG Uptake in Polyostotic Fibrous DysplasiaClinical Nuclear Medicine, 2007
- Unexpected finding of elevated glucose uptake in fibrous dysplasia mimicking malignancy: contradicting metabolism and morphology in combined PET/CTEuropean Radiology, 2006
- Risk assessment in liposarcoma patients based on FDG PET imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006
- Prognostic Significance of Preoperative [18-F] Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) Imaging in Patients With Resectable Soft Tissue SarcomasAnnals of Surgery, 2005
- The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysisCancer Treatment Reviews, 2004
- Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996